Skip to content

RNTX RNTX Additional Paid-In Capital

Additional Paid-In Capital at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$46.37B+0.8%
Gilead Sciences logo
Gilead SciencesGILD
$9.31B+14.3%
CTO
Citius Oncology, Inc.CTOR
$131.44M+47.2%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$674.86M+8.5%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$174.65M+26.4%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$1.59B+4.6%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's additional paid-in capital?
RNTX (RNTX) reported additional paid-in capital of $373.64M in Q1 2026.
How has RNTX's additional paid-in capital changed year-over-year?
RNTX's additional paid-in capital increased by 3.3% year-over-year, from $361.7M to $373.64M.
What is the long-term trend for RNTX's additional paid-in capital?
Over 5 years (2020 to 2025), RNTX's additional paid-in capital has grown at a 10.0% compound annual growth rate (CAGR), from $231.41M to $373.13M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.